查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1396848

葡萄醣醛酸内酯市场：按类型、应用和最终用户分类：2023-2032 年全球机会分析和产业预测

Glucuronolactone Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 300 Pages | 商品交期: 2-3个工作天内

价格

全球葡萄醣醛酸内酯市场预计将从2022年的380,308,600美元成长到2032年的617,293,300美元，2023年至2032年的复合年增长率为5.2%。

葡萄醣醛酸内酯是一种在食品中发现的化学物质，也在实验室中生产。葡萄醣醛酸内酯用作多种消费品的成分，包括机能饮料、营养补充和机能饮料。葡萄醣醛酸内酯与牛磺酸和咖啡馆一起存在于补充品中。它也可以与其他运动前物质（例如肌酸、β-丙氨酸和瓜氨酸）结合使用。葡萄醣醛酸内酯是红牛等能量饮料、许多运动前补充品和减肥蛋白质中的常见成分，已被证明可以增强体力和精神集中力。

久坐的生活方式和不健康饮食的增加正在推动市场成长。对 Rockstar、Red Bull 和 Monster 等速效释放产品的需求不断增长，推动了市场的扩张。此外，对洁净标示和植物来源产品的需求不断增长，以及对健康和积极生活方式的日益偏好，预计将在预测期内推动市场扩张。此外，製造商越来越多地使用 Instagram 和 YouTube 等社交媒体平台来宣传其体育用品，这可能会透过提高产品受欢迎程度来推动预测期内的市场扩张。此外，消费者可支配收入的增加和对运动营养的日益关注，加上人们对运动营养意识的增强，将推动新产品的开发。

葡萄醣醛酸内酯的高价格和葡萄醣醛酸内酯过量摄取的各种不良反应（如方向感丧失、头晕、心率加快等）预计将阻碍市场成长。围绕营养补充和葡萄醣醛酸内酯等功能性成分的监管环境正在不断发展。政府和监管机构越来越重视安全性、有效性和准确的标籤。随着法规变得更加严格，在葡萄醣醛酸内酯市场运营的公司可能在为其产品获得必要的核准和认证方面面临挑战。这些监管障碍可能导致产品发布延迟和额外的合规相关成本，从而阻碍市场成长前景。

增加对药品的投资有助于葡萄醣醛酸内酯产业的扩张。这是由于葡萄醣醛酸内酯在药品製造中的使用越来越多，它被用作添加剂以保持均匀性和其他特性。主要企业不断增加的技术创新预计将推动市场成长。例如，2019 年 3 月 28 日，我们在英国推出了首款能量饮料，与市场领导者可口可乐直接竞争，推动了对葡萄醣醛酸内酯的需求。这款新饮料含有咖啡馆、葡萄醣醛酸内酯、瓜拉那萃取物和 B 群维生素，针对 18 至 35 岁的人。

COVID-19 大流行对葡萄醣醛酸内酯市场产生了重大影响，影响了其动态的各个方面。供应链中断已成为一项重大挑战，封锁、旅行限制和劳动力减少影响了生产葡萄醣醛酸内酯所需的原材料的采购。这些中断，加上生产设施的关闭以及由于健康和安全协议而导致的营运能力下降，导致了含葡萄醣醛酸内酯产品的生产中断和潜在的供不应求。由于大流行，消费者对健康意识的转变进一步影响了对营养补充和葡萄醣醛酸内酯等功能性成分的需求。随着越来越多的消费者寻求支持其免疫力和整体健康的产品，市场经历了需求波动。此外，实体店的关闭增加了产品分销对线上销售管道的依赖，加速了产业内电子商务的趋势。

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 平均售价
  • 市场占有率分析
  • 品牌占有率分析
  • 贸易资料分析
  • 产品消费
  • 价值链分析
  • 监管指引
  • 关键监管分析
  • 赎回场景
  • 专利形势

第四章葡萄醣醛酸内酯市场：依类型

  • 概述
  • 粉末
  • 液体
  • 锭剂/胶囊

第五章葡萄醣醛酸内酯市场：依应用分类

  • 概述
  • 防腐剂
  • 抗氧化剂
  • 加工助剂/添加剂
  • 能量补充品

第六章葡萄醣醛酸内酯市场：依最终用户分类

  • 概述
  • 食品和饮料
  • 药品

第七章葡萄醣醛酸内酯市场：依地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他的

第八章 竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第九章 公司简介

  • Jungbunzlauer
  • Shandong Xinhong Pharmaceutical Co., Ltd.
  • Shandong Fuyuan Bio-Tech CO.LTD.
  • Merck Millipore Corporation
  • Shaoxing Marina Biotechnology Co.Ltd.
  • Shandong Baisheng Biotechnology Co., Ltd.
  • Roquette Freres
  • Functional Food chem International Corporation
  • Hubei Yitai Pharmaceutical Co.Ltd.
  • Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
Product Code: A13550

The global glucuronolactone market is anticipated to reach $6,17,293.3 thousand by 2032, growing from $3,80,308.6 thousand in 2022 at a CAGR of 5.2% from 2023 to 2032.

Glucuronolactone is a chemical found in food products and is also manufactured in laboratories. Glucuronolactone is used as an ingredient in various consumer products, including some energy drinks, dietary supplements, and functional beverages... Glucuronolactone is included in supplements alongside taurine and caffeine. It can also be used in conjunction with other pre-workout substances like as creatine, beta-alanine, and citrulline. Glucuronolactone is a common ingredient found in many energy drinks such as Red bull and a number of pre-workout supplements, and fat-loss proteins, and it is found to increase bodily strength and intellectual focus.

A growing sedentary lifestyle and consumption of an unhealthy diet are driving market growth. The increasing demand for immediate energy-releasing products such as Rockstar, Red Bull, and Monster has contributed to market expansion. Furthermore, increased demand for clean-label and plant-based goods, as well as a growing inclination for a healthy, active lifestyle, are predicted to drive market expansion throughout the projection period. Furthermore, the increased usage of social media platforms such as Instagram and YouTube by manufacturers to advertise sports items is likely to drive market expansion throughout the forecast period by increasing the popularity of products. Moreover, the increasing disposable income of the consumers, and rising focus on sports nutrition encourage new product development, coupled with the rising awareness of sports nutrition.

The high glucuronolactone prices and different adverse impacts of excessive glucuronolactone intake, like disorientation, dizziness, and fast heartbeat, are expected to hamper market growth. The regulatory landscape surrounding dietary supplements and functional ingredients like glucuronolactone is evolving. Governments and regulatory bodies are placing greater emphasis on safety, efficacy, and accurate labeling. As regulations become more stringent, companies operating in the glucuronolactone market might face challenges in obtaining the necessary approvals and certifications for their products. These regulatory hurdles can lead to delays in product launches and additional costs associated with compliance, hindering the growth prospects of the market.

Rising pharmaceutical investments are contributing to the glucuronolactone industry's expansion. This can be due to the growing use of glucuronolactone in medicine manufacture, where it is employed as an addition to preserve uniformity and other properties. Rising innovation by key companies in glucuronolactone is expected to drive market growth. For instance, on 28 March 2019, to compete directly with market leaders Coca Cola launched its first energy drink in the United Kingdom, driving demand for glucuronolactone. The new drink, which contains caffeine, glucuronolactone, guarana extracts, and B vitamins, is intended for those aged 18 to 35.

The COVID-19 pandemic has had significant impacts on the market for glucuronolactone, influencing various aspects of its dynamics. Supply chain disruptions emerged as a significant challenge, with lockdowns, restrictions on travel, and reduced workforce availability affecting the sourcing of raw materials necessary for glucuronolactone production. These disruptions, combined with manufacturing facility closures and reduced operational capacities due to health and safety protocols, led to production slowdowns and potential shortages of glucuronolactone-containing products. The pandemic-induced shift in consumer behavior towards health and wellness further influenced the demand for dietary supplements and functional ingredients like glucuronolactone. With consumers increasingly seeking products that support immunity and overall well-being, the market experienced fluctuations in demand. Additionally, the closure of physical retail outlets prompted a greater reliance on online sales channels for distributing products, accelerating the trend towards e-commerce within the industry.

The key players profiled in this report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., Roquette Freres. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the glucuronolactone market analysis from 2022 to 2032 to identify the prevailing glucuronolactone market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the glucuronolactone market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global glucuronolactone market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Investment Opportunities
  • Supply Chain Analysis & Vendor Margins
  • Technology Trend Analysis
  • Consumer Preference and Product Specifications
  • Market share analysis of players by products/segments
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Type

  • Powder
  • Liquid
  • Tablet/Capsule

By Application

  • Preservatives
  • Antioxidants
  • Processing Aids and Additives
  • Energy Supplements

By End User

  • Food and Beverages
  • Pharmaceuticals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Jungbunzlauer
    • Shandong Xinhong Pharmaceutical Co., Ltd.
    • Shandong Fuyuan Bio-Tech CO.LTD.
    • Merck Millipore Corporation
    • Shaoxing Marina Biotechnology Co.Ltd.
    • Shandong Baisheng Biotechnology Co., Ltd.
    • Roquette Freres
    • Functional Food chem International Corporation
    • Hubei Yitai Pharmaceutical Co.Ltd.
    • Anhui Fubore Pharmaceutical & Chemical Co.Ltd.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Regulatory Guidelines
  • 3.12. Key Regulation Analysis
  • 3.13. Reimbursement Scenario
  • 3.14. Patent Landscape

CHAPTER 4: GLUCURONOLACTONE MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Powder
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Liquid
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Tablet/Capsule
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: GLUCURONOLACTONE MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Preservatives
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Antioxidants
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Processing Aids and Additives
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Energy Supplements
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: GLUCURONOLACTONE MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Food and Beverages
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Pharmaceuticals
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: GLUCURONOLACTONE MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. UK
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. France
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Spain
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Italy
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. South Korea
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. Australia
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. United Arab Emirates
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. South Africa
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User
      • 7.5.5.5. Rest of LAMEA
      • 7.5.5.5.1. Market size and forecast, by Type
      • 7.5.5.5.2. Market size and forecast, by Application
      • 7.5.5.5.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Jungbunzlauer
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
  • 9.2. Shandong Xinhong Pharmaceutical Co., Ltd.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
  • 9.3. Shandong Fuyuan Bio-Tech CO.LTD.
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
  • 9.4. Merck Millipore Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
  • 9.5. Shaoxing Marina Biotechnology Co.Ltd.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
  • 9.6. Shandong Baisheng Biotechnology Co., Ltd.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
  • 9.7. Roquette Freres
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
  • 9.8. Functional Food chem International Corporation
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
  • 9.9. Hubei Yitai Pharmaceutical Co.Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
  • 9.10. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot

LIST OF TABLES

  • TABLE 01. GLOBAL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 02. GLUCURONOLACTONE MARKET FOR POWDER, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 03. GLUCURONOLACTONE MARKET FOR LIQUID, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 04. GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 05. GLOBAL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 06. GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 07. GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 08. GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 09. GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 10. GLOBAL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 11. GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 12. GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 13. GLUCURONOLACTONE MARKET, BY REGION, 2022-2032 ($THOUSAND)
  • TABLE 14. NORTH AMERICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 15. NORTH AMERICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 16. NORTH AMERICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 17. NORTH AMERICA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
  • TABLE 18. U.S. GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 19. U.S. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 20. U.S. GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 21. CANADA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 22. CANADA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 23. CANADA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 24. MEXICO GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 25. MEXICO GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 26. MEXICO GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 27. EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 28. EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 29. EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 30. EUROPE GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
  • TABLE 31. GERMANY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 32. GERMANY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 33. GERMANY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 34. UK GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 35. UK GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 36. UK GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 37. FRANCE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 38. FRANCE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 39. FRANCE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 40. SPAIN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 41. SPAIN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 42. SPAIN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 43. ITALY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 44. ITALY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 45. ITALY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 46. REST OF EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 47. REST OF EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 48. REST OF EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 49. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 50. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 51. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 52. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
  • TABLE 53. CHINA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 54. CHINA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 55. CHINA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 56. JAPAN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 57. JAPAN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 58. JAPAN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 59. INDIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 60. INDIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 61. INDIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 62. SOUTH KOREA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 63. SOUTH KOREA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 64. SOUTH KOREA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 65. AUSTRALIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 66. AUSTRALIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 67. AUSTRALIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 68. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 69. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 70. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 71. LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 72. LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 73. LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 74. LAMEA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)
  • TABLE 75. BRAZIL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 76. BRAZIL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 77. BRAZIL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 78. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 79. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 80. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 81. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 82. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 83. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 84. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 85. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 86. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 87. REST OF LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)
  • TABLE 88. REST OF LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)
  • TABLE 89. REST OF LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)
  • TABLE 90. JUNGBUNZLAUER: KEY EXECUTIVES
  • TABLE 91. JUNGBUNZLAUER: COMPANY SNAPSHOT
  • TABLE 92. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 93. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 94. SHANDONG FUYUAN BIO-TECH CO.LTD.: KEY EXECUTIVES
  • TABLE 95. SHANDONG FUYUAN BIO-TECH CO.LTD.: COMPANY SNAPSHOT
  • TABLE 96. MERCK MILLIPORE CORPORATION: KEY EXECUTIVES
  • TABLE 97. MERCK MILLIPORE CORPORATION: COMPANY SNAPSHOT
  • TABLE 98. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: KEY EXECUTIVES
  • TABLE 99. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: COMPANY SNAPSHOT
  • TABLE 100. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES
  • TABLE 101. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 102. ROQUETTE FRERES: KEY EXECUTIVES
  • TABLE 103. ROQUETTE FRERES: COMPANY SNAPSHOT
  • TABLE 104. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: KEY EXECUTIVES
  • TABLE 105. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 106. HUBEI YITAI PHARMACEUTICAL CO.LTD.: KEY EXECUTIVES
  • TABLE 107. HUBEI YITAI PHARMACEUTICAL CO.LTD.: COMPANY SNAPSHOT
  • TABLE 108. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: KEY EXECUTIVES
  • TABLE 109. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: COMPANY SNAPSHOT

LIST OF FIGURES

  • FIGURE 01. GLUCURONOLACTONE MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF GLUCURONOLACTONE MARKET,2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN GLUCURONOLACTONE MARKET (2023-2032)
  • FIGURE 04. BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. BARGAINING POWER OF BUYERS
  • FIGURE 06. THREAT OF SUBSTITUTION
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. COMPETITIVE RIVALRY
  • FIGURE 09. GLOBAL GLUCURONOLACTONE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. REGULATORY GUIDELINES: GLUCURONOLACTONE MARKET
  • FIGURE 11. IMPACT OF KEY REGULATION: GLUCURONOLACTONE MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. GLUCURONOLACTONE MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR POWDER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR LIQUID, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. GLUCURONOLACTONE MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. GLUCURONOLACTONE MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 27. U.S. GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 28. CANADA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 29. MEXICO GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 30. GERMANY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 31. UK GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 32. FRANCE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 33. SPAIN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 34. ITALY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 35. REST OF EUROPE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 36. CHINA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 37. JAPAN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 38. INDIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 39. SOUTH KOREA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 40. AUSTRALIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 41. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 42. BRAZIL GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 43. SAUDI ARABIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 44. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 45. SOUTH AFRICA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 46. REST OF LAMEA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: GLUCURONOLACTONE MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2022